Patrick R. Trucchio
Stock Analyst at HC Wainwright & Co.
(4.50)
# 269
Out of 5,090 analysts
42
Total ratings
61.9%
Success rate
19.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick R. Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHVS Pharvaris | Reiterates: Buy | $60 | $26.42 | +127.10% | 3 | Dec 3, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $80 → $85 | $61.44 | +38.35% | 3 | Dec 2, 2025 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Buy | $55 | $39.83 | +38.09% | 2 | Nov 24, 2025 | |
| ONCY Oncolytics Biotech | Maintains: Buy | $5 → $10 | $0.99 | +907.96% | 1 | Nov 17, 2025 | |
| CYBN Cybin | Maintains: Buy | $150 → $55 | $5.99 | +818.20% | 1 | Nov 14, 2025 | |
| VYGR Voyager Therapeutics | Maintains: Buy | $30 → $25 | $4.28 | +484.11% | 2 | Nov 12, 2025 | |
| GHRS GH Research | Maintains: Buy | $40 → $35 | $14.89 | +135.06% | 1 | Nov 10, 2025 | |
| QURE uniQure | Maintains: Buy | $110 → $70 | $21.33 | +228.18% | 5 | Nov 4, 2025 | |
| IVVD Invivyd | Maintains: Buy | $5 → $10 | $2.23 | +348.43% | 3 | Nov 3, 2025 | |
| ANRO Alto Neuroscience | Maintains: Buy | $10 → $50 | $13.43 | +272.30% | 2 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $38.78 | +157.86% | 1 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.24 | +129.01% | 2 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $2.36 | +1,594.92% | 3 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $35.01 | +42.82% | 1 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $27.09 | +195.31% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $570 | $458.12 | +24.42% | 2 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.32 | +247.22% | 1 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $6.96 | +977.59% | 1 | Sep 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $6.50 | +130.77% | 1 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $80.50 | +5.59% | 2 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $9.99 | +400.50% | 2 | Sep 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $0.50 | +1,916.54% | 1 | Sep 4, 2025 |
Pharvaris
Dec 3, 2025
Reiterates: Buy
Price Target: $60
Current: $26.42
Upside: +127.10%
Arrowhead Pharmaceuticals
Dec 2, 2025
Maintains: Buy
Price Target: $80 → $85
Current: $61.44
Upside: +38.35%
Harmony Biosciences Holdings
Nov 24, 2025
Reiterates: Buy
Price Target: $55
Current: $39.83
Upside: +38.09%
Oncolytics Biotech
Nov 17, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $0.99
Upside: +907.96%
Cybin
Nov 14, 2025
Maintains: Buy
Price Target: $150 → $55
Current: $5.99
Upside: +818.20%
Voyager Therapeutics
Nov 12, 2025
Maintains: Buy
Price Target: $30 → $25
Current: $4.28
Upside: +484.11%
GH Research
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $14.89
Upside: +135.06%
uniQure
Nov 4, 2025
Maintains: Buy
Price Target: $110 → $70
Current: $21.33
Upside: +228.18%
Invivyd
Nov 3, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $2.23
Upside: +348.43%
Alto Neuroscience
Oct 24, 2025
Maintains: Buy
Price Target: $10 → $50
Current: $13.43
Upside: +272.30%
Oct 22, 2025
Reiterates: Buy
Price Target: $100
Current: $38.78
Upside: +157.86%
Oct 20, 2025
Reiterates: Buy
Price Target: $12
Current: $5.24
Upside: +129.01%
Oct 16, 2025
Reiterates: Buy
Price Target: $40
Current: $2.36
Upside: +1,594.92%
Oct 14, 2025
Reiterates: Buy
Price Target: $50
Current: $35.01
Upside: +42.82%
Oct 10, 2025
Reiterates: Buy
Price Target: $80
Current: $27.09
Upside: +195.31%
Oct 10, 2025
Reiterates: Buy
Price Target: $570
Current: $458.12
Upside: +24.42%
Sep 23, 2025
Reiterates: Buy
Price Target: $15
Current: $4.32
Upside: +247.22%
Sep 16, 2025
Reiterates: Buy
Price Target: $75
Current: $6.96
Upside: +977.59%
Sep 15, 2025
Reiterates: Buy
Price Target: $15
Current: $6.50
Upside: +130.77%
Sep 15, 2025
Reiterates: Buy
Price Target: $85
Current: $80.50
Upside: +5.59%
Sep 12, 2025
Reiterates: Buy
Price Target: $50
Current: $9.99
Upside: +400.50%
Sep 4, 2025
Reiterates: Buy
Price Target: $10
Current: $0.50
Upside: +1,916.54%